The progres of civilization and the emergence of new pathogens requires the development of a rapid strategy for the production of novel commercial diagnostic tests and therapies. Our first mission in 2016 was to develop a NaNoEXPO system that enable researchers (R&D) to test different antigens/epitopes and to accelerate the process of development of diagnostic and therapeutic tools, including vaccines.
The NaNoEXPO system can be applicable in the:
The current civilization need has contributed to the detection and monitoring of numerous diseases, many of which are caused by new etiological agents. Therefore, in 2019 we responded to the global needs offering not only the NanoExpo system as a innovative solution for different purpose, but also ready to use products (such as VLPs) and services in bioengineering of biological nanostructures personalised to individual customer needs (e.g., exposure of selected epitopes/peptides on the surface of nanostructures, chimeric virus-like particles (VLPs), as well as biological nanostructures able to carry genetic material).
Our technology is based on bioengineered biological nanostructures as a universal platform/ delivery system that enables the production of new generation antiges for diagnostic and as therapeutics. NaNoExpo system has been optimized for different expression systems for efficient VLP production within a few weeks.
Our biological nanostructures can serve as:
⦁ antiges that characterised with proper native conformation – for development of diagnostic tests
⦁ Virus – like particles – for basic studies as well as for the development of diagnostic tests or therapeutics and vaccines
• antigen carriers - foreign antigens presented as linear or structural epitopes on the particle surface
• delivery tools – encapsulation of genetic material such as DNA or therapeutic mRNA or drug.